Federal Register notice: FDA announces a 6/12 public workshop entitled Advancing the Development and Implementation of Analysis Data Standards: Key Ch...
NIH director Francis Collins says a study found that dietary supplements do not extend life for most people in the general population.
CBER director Peter Marks posts an FY 2018 annual report highlighting Center accomplishments including approval of two gene therapies and three vaccin...
FDA Oncology Center of Excellence director Richard Pazdur quizzes cancer immunotherapeutics makers on whether there are too many of their products on ...
FDA grants Advanced Prenatal Therapeutics a breakthrough device designation for its Targeted Apheresis Column for Preeclampsia.
FDA grants Intensity Therapeutics a fast track designation for INT230-6 and its use in treating patients with relapsed or metastatic triple negative b...
Federal Register notice: FDA announces the withdrawal of 31 ANDAs from multiple applicants because they are no longer marketed.
Hi-Tech Pharmaceuticals accuses FDA of bullying it into withdrawing its dietary supplements containing DMHA.